Recognition of hemophilia in women and girls is better, but challenges remain in getting accurate diagnoses and proper care, ...

Columnist Allyx Formalejo offers a meditation on the path toward finding balance in a relationship in the midst of difficult ...

Columnist Jennifer Lynne shares how she addresses chronic pain and structural damage from her various bleeding disorders.

It can be easy to judge people whose illness is invisible, says columnist Cazandra Campos-MacDonald, but let's try to show empathy instead.

Columnist Jennifer Lynne says MASAC guidelines on screening for iron deficiency may be a game-changer for people with bleeding disorders.

Early genetic testing done during IVF may be an option to help couples affected by hemophilia have healthy babies, a 10-year ...

Experimental treatment denecimig maintained low bleed rates in hemophilia A, with safety findings consistent with earlier ...

Columnist Allyx Formalejo writes how living with her husband's hemophilia changed her relationship with the goals she had set ...

A standard hemophilia assessment tool underestimates joint damage in female patients because it uses male reference values, a ...

Jennifer Lynne is an entrepreneur specializing in digital marketing, a self-professed computer nerd, and a nationally competitive Scrabble player. Jennifer has strong ties to the bleeding disorder ...

Hemophilia B Leyden (HBL) is a sub-type of hemophilia B, a genetic bleeding disorder characterized by a lack of a blood-clotting protein called factor IX. HBL accounts for approximately 3% of all ...

Novo Nordisk has submitted an application to the U.S. Food and Drug Administration seeking approval to market Mim8 (denecimig), an injection therapy for preventing bleeds in people with hemophilia A ...